To access this element change to forms mode OFF
Grant Award View - GA409694
Accelerating vaccine development for Plasmodium vivax malaria
GA ID:
GA409694
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2024
Publish Date:
23-Dec-2024
Category:
Medical Research
Grant Term:
1-Jan-2025 to 31-Dec-2027
Value (AUD):
$824,611.48
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 23/24 1.1 Health and Medical Research
Grant Program:
International Joint Calls
Grant Activity:
Accelerating vaccine development for Plasmodium vivax malaria
Purpose:
Malaria due to P. vivax is a major global health problem, especially in the Asia-Pacific region. The development of an effective vaccine would greatly facilitate achieving malaria elimination goals set by the WHO. However, there are very few P. vivax vaccines in development and very few candidates have been identified. Our project will use multiple complementary approaches to select and prioritize P. vivax merozoite antigens for vaccine development using the mRNA vaccine platform.
GO ID:
GO Title:
NHMRC e-ASIA 2024 Joint Research Program funding commencing in 2025
InternalReferenceId:
2024/GNT2036102
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Burnet Institute
Recipient ABN:
49 007 349 984
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA